Welcome

"Out of clutter, find simplicity. From discord, find harmony. In the middle of difficulty, find opportunity." - Albert Einstein


Welcome. In the recent months, I've had many conversations with my friends and colleagues here in Silicon Valley regarding the formulation, design, development and growth of a broad variety of companies (from medical device to consumer products to SaaS) and their products.

In the course of these discussions, we've exchanged a variety of information we've found useful in these endeavors - healthcare trends, technology, funding, design, manufacturing, etc. I've compiled a set of this information here to a) ease the exchange of this information and b) facilitate the creation of great companies.

To be clear, this is not intended as a comprehensive compilation of industry news and data, but rather a set of information and insights which we've found useful. Also note that this is a compilation of information from a variety of sources, some independent, some with an agenda. As such, the authors own their own material and "the opinions of the authors are their own".

Reader tip: I'd suggest you use the "Topics, Categories and Labels" section to go directly to those posts of most interest to you.

Monday, April 8, 2013

Cooley Godward Venture Financing Report 2012


Deal Volumes Slow as Valuations Stabilize. 

From Cooley: "Overall, our data pointed to a year marked by slowing deal volumes and stabilizing valuations. In 2012, we saw aggregate dollars raised reach $4.9 billion, down from $6 billion in 2011. The decrease in both deal volumes and invested capital was driven by a slowing financing environment during the second half of 2012. Median pre-money valuations were relatively flat across all deal stages with the exception of Series B transactions. We saw an increase in up versus flat/down rounds. Up rounds represented 75% of all financings in 2012, a level not seen since 2007. Additionally, the percentage of recapitalization transactions fell in 2012, as well as the number of tranched deals. Deal terms also mirrored the financing statistics. The utilization of fully participating preferred provisions was relatively flat from 2011 and we witnessed a decrease in pay-to-play provisions in 2012, compared to the prior year".


Cooley Venture Financing Report - 2012 Year in Review
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)